undamentalytics Newsletter

Si-bone, Inc. income statement

In fiscal 2025, Si-bone, Inc. reported revenue of $201m, up 20.2% on the year before, operating income of −$22.3m (a -11.1% margin) and net income of −$18.9m, or −$0.44 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Si-bone, Inc.: income statement, annual
Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue4855677390106139167201214
Cost of revenue5579101629354144
Gross profit435161648091109132160170
Research and development6579121415171718
Selling and marketing4244687494108110117124130
General and administrative13132120252931344140
Operating income−17−12−36−39−52−60−47−35−22−18
Interest expense6556533332
Income before tax−23−17−38−44——————
Income tax00——000000
Net income−23−17−38−44−57−61−43−31−19−15
Diluted EPS−$2.22−$0.73−$1.55−$1.50−$1.71−$1.79−$1.13−$0.75−$0.44−$0.33
Diluted shares (average)10m24m25m29m33m34m38m41m43m44m
EBITDA−16−11−35−37−50−56−42−31−17−11

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: SIBN vs TMCILAKE vs SIBNESTA vs SIBN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Si-bone, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Si-bone, Inc.